Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced Melanoma
Phase 1
Terminated
- Conditions
- Melanoma
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2016-04-22
- Lead Sponsor
- AGIRx Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT00716495
- Locations
- 🇵🇱
WCO (Great Poland Cancer Centre), Poznan, Poland
News
No news found